胃がん治療におけるCLDN18.2発現の再検討
Peng Luo1, Hank Z H Wong2, Dan Shan3
1Jiangnan University Smart Healthcare Joint Laboratory, Donghai County People's Hospital, Lianyungang, China; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Lancet (London, England)
|January 10, 2026
まとめ
No abstract available in PubMed .
さらに関連する動画
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.6K
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
4.7K
